Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

BioMarin Pharmaceutical Inc. buy Morgan Stanley

Start price
€75.64
26.04.24 / 50%
Target price
€104.69
26.04.25
Performance (%)
0.82%
Price
€76.26
06.05.24
Summary
This prediction is currently active. Since the start of the prediction for BioMarin Pharmaceutical Inc. the price has only changed by 0.82%. This prediction currently runs until 26.04.25. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this prediction
Performance without dividends (%)
Name 1w
BioMarin Pharmaceutical Inc. -0.470%
iShares Core DAX® 0.476%
iShares Nasdaq 100 1.290%
iShares Nikkei 225® 1.300%
iShares S&P 500 0.829%

Comments by Morgan_Stanley for this prediction

In the thread BioMarin Pharmaceutical Inc. diskutieren
Prediction Buy
Perf. (%) 0.82%
Target price 104.686
Change
Ends at 26.04.25

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its price target lowered by analysts at Morgan Stanley from $115.00 to $112.00. They now have an "overweight" rating on the stock.
Ratings data for BMRN provided by MarketBeat

Stopped prediction by Morgan_Stanley for BioMarin Pharmaceutical Inc.

buy
BioMarin Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€79.72
01.08.23
€113.91
01.08.24
-4.34%
06.05.24